会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 55. 发明授权
    • Streptococcus uberis protein, nucleic acid sequence encoding the same and its use in a mastitis vaccine
    • 乳房链球菌蛋白,编码相同的核酸序列及其在乳腺炎疫苗中的应用
    • US07601804B2
    • 2009-10-13
    • US10524198
    • 2003-08-06
    • Petrus Johannes Maria NuijtenSelma Marianne Hensen
    • Petrus Johannes Maria NuijtenSelma Marianne Hensen
    • C07K1/00G01N33/569
    • C07K14/315A61K39/00
    • The present invention relates to nucleic acid sequences encoding a 22.5 kD Streptococcus uberis protein and to parts of such nucleic acid sequences that encode an immunogenic fragment of such proteins, and to DNA fragments, recombinant DNA molecules, live recombinant carriers and host cells comprising such nucleic acid sequences or such parts thereof. The invention also relates to a 22.5 kD Streptococcus uberis protein and immunogenic parts thereof encoded by such sequences. Furthermore, the present invention relates to vaccines comprising such nucleic acid sequences and parts thereof, DNA fragments, recombinant DNA molecules, live recombinant carriers and host cells comprising such nucleic acid sequences or such parts thereof, proteins or immunogenic parts thereof and antibodies against such proteins or immunogenic parts thereof. Also, the invention relates to the use of said proteins in vaccines and for the manufacture of vaccines. Moreover, the invention relates to the use of said nucleic acid sequences, proteins or antibodies for diagnostic or vaccination purposes. Finally the invention relates to diagnostic kits comprising such a nucleic acid, protein or antibodies against such protein.
    • 本发明涉及编码22.5kD乳房链球菌蛋白质的核酸序列和编码这种蛋白质的免疫原性片段的这些核酸序列的部分,以及DNA片段,重组DNA分子,活重组载体和包含该核酸的宿主细胞 酸序列或其部分。 本发明还涉及由这样的序列编码的22.5kD乳房链球菌蛋白及其免疫原性部分。 此外,本发明涉及包含此类核酸序列及其部分的DNA疫苗,DNA片段,重组DNA分子,活重组载体和包含此类核酸序列或其部分的宿主细胞,蛋白质或其免疫原性部分和针对此类蛋白质的抗体 或其免疫原性部分。 此外,本发明涉及所述蛋白质在疫苗中的用途以及制造疫苗。 此外,本发明涉及用于诊断或疫苗接种目的的所述核酸序列,蛋白质或抗体的用途。 最后,本发明涉及包含这种核酸,蛋白质或抗这种蛋白质的抗体的诊断试剂盒。
    • 56. 发明授权
    • Prime-boost vaccine for the protection of equines against viral infection
    • 用于保护马免受病毒感染的Prime-boost疫苗
    • US07601500B2
    • 2009-10-13
    • US11743492
    • 2007-05-02
    • Saskia van de Zande
    • Saskia van de Zande
    • C12Q1/68
    • A61K39/145A61K39/12A61K2039/5254A61K2039/545A61K2039/552A61K2039/55511A61K2039/55577C12N2760/16134
    • It has been found that adequate protection against viral infection in equines can be achieved when vaccination with a live viral vaccine (prime) is followed by vaccination with an inactivated vaccine (boost) for the same virus, wherein the two shots are given no longer than 8 weeks apart.The invention therefore provides a method for vaccination of equines against infection with an equine viral pathogen, wherein an animal is first vaccinated with a (prime) vaccine comprising an attenuated form of the pathogen, followed by a vaccination with a (boost) vaccine comprising the same pathogen in inactivated form, and wherein the boost vaccine is administered no longer than eight weeks after the prime vaccine.The method of the invention is especially useful for vaccination against viral infections such as infections with EIV and/or EHV-1/EHV-4.Especially for EIV, it has been found that when equines are vaccinated with such a prime-boost vaccine regimen according to the invention, the equines are protected against clinical signs after a challenge with a virulent EIV.
    • 已经发现,当用活病毒疫苗(初始)接种疫苗之后,用相同病毒的灭活疫苗(增强)接种疫苗后,可以实现对马中的病毒感染的充分保护,其中两次照射不再 相隔8周。 因此,本发明提供了一种针对马病毒病原体感染马的疫苗接种方法,其中动物首先用包含减毒形式的病原体的(初级)疫苗接种疫苗,然后用(加强)疫苗接种疫苗,其包含 相同的灭活形式的病原体,并且其中所述加强疫苗在所述主要疫苗之后不超过8周施用。 本发明的方法对于针对病毒感染例如EIV和/或EHV-1 / EHV-4感染是特别有用的。 特别是对于EIV,已经发现,当使用根据本发明的初始 - 加强疫苗方案接种马时,在用有毒EIV攻击后,马被保护免受临床症状。
    • 58. 发明授权
    • Helicobacter felis vaccine
    • 幽门螺杆菌疫苗
    • US07514547B2
    • 2009-04-07
    • US09904994
    • 2001-07-13
    • Johannes Gerardus KustersGiovanni Cattoli
    • Johannes Gerardus KustersGiovanni Cattoli
    • A61K39/00
    • C12N9/80A61K39/00C07K14/205
    • The present invention relates to novel Helicobacter felis urease subunit polypeptides and to nucleic acid sequences encoding these subunit polypeptides, to DNA fragments and recombinant DNA molecules comprising the nucleic acid sequences encoding these subunit polypeptides, to live recombinant carriers and to host cells comprising nucleic acid sequences encoding these subunit polypeptides. Also, the invention relates to the subunit polypeptides for use in vaccines and the use in the manufacturing thereof, to vaccines comprising said subunit polypeptides and to methods for the preparation of such vaccines. Furthermore, the invention relates to diagnostic methods for the detection of Helicobacter felis specific nucleic acid sequences, Helicobacter felis antigenic material and to antibodies against Helicobacter felis.
    • 本发明涉及新颖的幽门螺杆菌脲酶亚基多肽和编码这些亚单位多肽的核酸序列,涉及包含编码这些亚单位多肽的核酸序列的DNA片段和重组DNA分子,以及包含核酸序列的宿主细胞 编码这些亚基多肽。 此外,本发明还涉及用于疫苗的亚单位多肽及其制备中使用的疫苗,包括所述亚单位多肽的疫苗以及制备这种疫苗的方法。 此外,本发明涉及用于检测幽门螺杆菌特异性核酸序列,幽门螺杆菌抗原物质和针对幽门螺杆菌抗体的诊断方法。
    • 59. 发明授权
    • Lawsonia intracellularis vaccine
    • 细胞内毒素疫苗
    • US07491401B2
    • 2009-02-17
    • US11180997
    • 2005-07-13
    • Antonius Arnoldus Christiaan JacobsPaul Vermeij
    • Antonius Arnoldus Christiaan JacobsPaul Vermeij
    • A61K39/02C07H21/04C12P21/04
    • C07K14/205A61K38/00A61K39/00A61K48/00C07K14/195
    • The present invention relates i.a. to nucleic acid sequences encoding novel Lawsonia intracellularis proteins. It furthermore relates to DNA fragments, recombinant DNA molecules and live recombinant carriers comprising these sequences. Also it relates to host cells comprising such nucleic acid sequences, DNA fragments, recombinant DNA molecules and live recombinant carriers. Moreover, the invention relates to proteins encoded by these nucleotide sequences. The invention also relates to vaccines for combating Lawsonia intracellularis infections and methods for the preparation thereof. Finally the invention relates to diagnostic tests for the detection of Lawsonia intracellularis DNA, the detection of Lawsonia intracellularis antigens and of antibodies against Lawsonia intracellularis.
    • 本发明涉及到 涉及编码新的细胞内劳森氏菌蛋白质的核酸序列。 此外,它还涉及包含这些序列的DNA片段,重组DNA分子和活重组载体。 此外,它涉及包含这种核酸序列的宿主细胞,DNA片段,重组DNA分子和活重组载体。 此外,本发明涉及由这些核苷酸序列编码的蛋白质。 本发明还涉及用于防治细胞内劳森氏菌感染的疫苗及其制备方法。 最后本发明涉及检测细胞内劳森氏菌DNA,检测细胞内劳森氏菌抗原和针对细胞内劳森氏菌的抗体的诊断试验。
    • 60. 发明申请
    • Novel Brachyspira hyodysenteriae vaccine
    • 新型短螺旋体猪链球菌疫苗
    • US20090017048A1
    • 2009-01-15
    • US12047188
    • 2008-03-12
    • Ben AdlerPaul Antony CullenScott Adam James CouttsDieter Mark BulachRuud Philip Antoon Maria Segers
    • Ben AdlerPaul Antony CullenScott Adam James CouttsDieter Mark BulachRuud Philip Antoon Maria Segers
    • A61K39/02C07H21/04A61P31/04C12N5/06
    • C07K14/20A61K39/00A61K2039/505A61K2039/523A61K2039/53
    • The present invention relates to nucleic acid sequences encoding a 61 kD and a 20 kD Brachyspira hyodysenteriae lipoprotein and to parts of such nucleic acid sequences that encode an immunogenic fragment of such lipoproteins, and to DNA fragments, recombinant DNA molecules, live recombinant carriers and host cells comprising such nucleic acid sequences or such parts thereof. The invention also relates to a 61 kD and a 20 kD Brachyspira hyodysenteriae lipoprotein and immunogenic parts thereof encoded by such sequences. Furthermore, the present invention relates to vaccines comprising such nucleic acid sequences and parts thereof, DNA fragments, recombinant DNA molecules, live recombinant carriers and host cells comprising such nucleic acid sequences or such parts thereof, lipoproteins or immunogenic parts thereof and antibodies against such lipoproteins or immunogenic parts thereof. Also, the invention relates to the use of said lipoproteins in vaccines and for the manufacture of vaccines. Moreover, the invention relates to the use of said nucleic acid sequences, lipoproteins or antibodies for diagnostic or vaccination purposes. Finally the invention relates to diagnostic kits comprising such a nucleic acid, lipoprotein or antibodies against such lipoprotein.
    • 本发明涉及编码61kD和20kD猪链霉菌血脂蛋白脂蛋白的核酸序列以及编码这种脂蛋白的免疫原性片段的这些核酸序列的部分,以及DNA片段,重组DNA分子,活重组载体和宿主 包含这样的核酸序列的细胞或其部分。 本发明还涉及由这样的序列编码的61kD和20kD猪链球菌脂蛋白及其免疫原性部分。 此外,本发明涉及包含此类核酸序列及其部分的DNA疫苗,DNA片段,重组DNA分子,活重组载体和包含此类核酸序列或其部分的宿主细胞,脂蛋白或其免疫原性部分和针对此类脂蛋白的抗体 或其免疫原性部分。 此外,本发明还涉及所述脂蛋白在疫苗中的用途以及制造疫苗。 此外,本发明涉及所述核酸序列,脂蛋白或抗体用于诊断或疫苗接种目的的用途。 最后,本发明涉及包含这种核酸,脂蛋白或抗这种脂蛋白的抗体的诊断试剂盒。